Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that Sanguisorba Officinalis Root Extract showed potential in reducing hair loss by inhibiting FGF-5 activity, extending hair growth phases in mice and reducing hair loss in human trials.

This study found that among individuals with hair loss-related conditions, there was a significant association between alopecia and anxiety disorders, with affected individuals experiencing anxiety more frequently.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

In this study, 8-week hair loss management combined with aroma scalp massage did not significantly change hair thickness or density but improved scalp moisture and subjective satisfaction among 16 participants aged 20–50.

In this study, researchers proposed a deep learning approach combining genetic, hormonal, scalp health, and lifestyle data to predict hair loss, employing CNNs for image analysis and RNNs for modeling data over time, although specific results are not reported.

This study found that alopecia areata patients with eosinophilia were more likely to have severe hair loss, atopia, and nail abnormalities compared to those without eosinophilia.

This study reports that various types of alopecia, including permanent alopecia, can persist after an acute DRESS episode, but telogen effluvium and alopecia areata showed clinical improvement with treatment within six months.

In this study conducted in the Makkah region, researchers observed that hair loss, mostly telogen effluvium, is a prevalent post-COVID-19 symptom, particularly among women and those with multiple health issues.

This study found that female pattern hair loss was common in postmenopausal women, with body mass index being a significant associated factor.

This study reported that a specific mixing ratio of Dendropanax extract and sea salt showed low cytotoxicity, high cell proliferation, anti-inflammatory, and antimicrobial effects, suggesting potential for functional cosmetics against hair loss.

This review reports that clinical studies generally showed favorable results for microneedling as an adjunct therapy for androgenic alopecia and alopecia areata, despite the low quality of existing data.

This study aimed to explore the demographic factors linked to stress-induced hair loss among medical students, although it reports no new results on this relationship.

In this study, HED patients with COVID-19 showed a higher risk of postinfection fatigue and hair loss compared to controls, suggesting they are more susceptible to long-term consequences of SARS-CoV-2 infection.

This review highlights existing research on the psychological effects of the COVID-19 pandemic, particularly noting increased depression and anxiety among women, but presents no new study results.

This study identified a new genetic variant in the KRT71 gene responsible for a breed-specific form of hypotrichosis in Hereford cattle, potentially serving as a model for similar human conditions.

This article discusses COVID-19-induced hair loss, noting that both the infection and related stress may contribute to diffuse thinning and androgenic alopecia, and emphasizes the importance of dermatological evaluation.

This case study describes hair loss as a potential late complication of multisystem inflammatory syndrome in children, observed in a 7-year-old girl who developed Telogen effluvium 73 days post-diagnosis.

In this case series, the topical botanical formulation GASHEE demonstrated significant improvements in hair regrowth without adverse events among patients with hair loss, including cases where previous treatments had failed.

This review examines the various potential causes of bitemporal hair loss, emphasizing the importance of prompt diagnosis to prevent further hair loss in scarring conditions; it reports no new clinical results.

This study found that several factors, including ponytail hairstyles and alcohol consumption, were associated with increased severity of female pattern hair loss in the surveyed Chinese women.

This study found that consuming 100 mg of pea sprout extract daily for 8 weeks significantly reduced hair loss in individuals experiencing excessive hair shedding.

This case report describes a patient with autoimmune autonomic neuropathy associated with high-titer gAChR antibodies who developed selective pigmented hair loss during IV immunoglobulin treatment.

This study found that in female breast cancer patients, supplementation with 400 mg IND02 (Cinnamon bark extract) thrice daily during chemotherapy significantly reduced severe weight loss and hair loss compared to placebo, with the treatment being well-tolerated and safe.

This article provides no new data as it is a letter to the editor and lacks an abstract, focusing instead on discussing aspects of hair loss in the elderly without presenting research results.

This study found that the adult population in Majmaah, Saudi Arabia, has limited knowledge and practice regarding vitamin D deficiency, despite widespread awareness from media sources.

This case report describes a 13-year-old girl with epilepsy who experienced hair loss within two months of starting levetiracetam, marking it as the first report of this side effect in this age group.

This case report suggests that methylphenidate may lead to hair loss in some patients, observable when stopping and starting the medication.

In this study, focal atrichia was associated with late-onset female pattern hair loss, providing a clinical clue to its diagnosis, particularly separating it from other hair disorders.

Agomelatine might help stop hair loss caused by valproate.

This abstract reviews existing hair loss treatments, highlighting FDA-approved drugs like Minoxidil and Finasteride while noting growing interest in herbal alternatives due to concerns about potential long-term side effects.